These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7871913)

  • 41. The relationship between oral contraceptive use, cancer and vascular disease.
    La Vecchia C; Franceschi S; Bruzzi P; Parazzini F; Boyle P
    Drug Saf; 1990; 5(6):436-46. PubMed ID: 2285497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A cytologic diagnosis of breast secretions--application of cytology to the mass survey of breast cancer].
    Fujii M; Ishii Y; Nagao M; Wakabayashi T; Fukahori S; Goto A; Tomono T; Hagiwara K
    Gan No Rinsho; 1988 Feb; 34(2):174-8. PubMed ID: 3346995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral contraceptives and depression.
    Warnes H; Fitzpatrick C
    Psychosomatics; 1979 Mar; 20(3):187-9, 193-4. PubMed ID: 441235
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Side effects of oral contraceptives].
    Khomasuridze AG
    Akush Ginekol (Mosk); 1983 Nov; (11):27-9. PubMed ID: 6666793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Mammograms in women taking oral contraceptives (author's transl)].
    Brezina K; Janisch H; Müller-Tyl E
    Wien Klin Wochenschr; 1973 Nov; 85(48):785-90. PubMed ID: 4796259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liver-cell adenomas associated with use of oral contraceptives.
    Edmondson HA; Henderson B; Benton B
    N Engl J Med; 1976 Feb; 294(9):470-2. PubMed ID: 173996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Minipill as the new contraceptive method].
    Lambotte R; Werbrouck-Navette J
    Rev Med Liege; 1974 Mar; 29(6):157-9. PubMed ID: 4817042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
    Weikel JH; Nelson LW
    J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of an oral contraceptive (ethinylestradiol/D-norgestrel) on growth hormone and insulin secretion].
    Hausmann L; Goebel KM; Zehner J
    Schweiz Med Wochenschr; 1976 Oct; 106(43):1470-4. PubMed ID: 1013665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The pill and cancer of the breast and cervix uteri].
    Pedersen A
    Ugeskr Laeger; 1984 Apr; 146(14):1063-6. PubMed ID: 6730039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-dose oral contraceptives are safer than high-dose pills.
    Lidegaard O
    Am J Obstet Gynecol; 1995 Jun; 172(6):1950-1. PubMed ID: 7778663
    [No Abstract]   [Full Text] [Related]  

  • 54. When parents do not want their daughters on birth control pills: tips for navigating a difficult clinical situation.
    Perriera LK; Greenfield M
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):79-81. PubMed ID: 22319794
    [No Abstract]   [Full Text] [Related]  

  • 55. Cytological study of nipple secretions; an aid in the diagnosis of breast lesions.
    JACKSON D; SEVERANCE AO
    Tex State J Med; 1946 Feb; 41():512-4. PubMed ID: 21012167
    [No Abstract]   [Full Text] [Related]  

  • 56. [Mild, moderate and severe dysplasia in exfoliative cytological studies of breast secretions in connection with use of oral contraceptives].
    Wunderlich M
    Zentralbl Gynakol; 1994; 116(11):622-7. PubMed ID: 7871913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Breast diseases (fibroadenomas, mastopathies, breast cancers) in hormonal contraception].
    Nizze H; Kändler U
    Zentralbl Gynakol; 1988; 110(20):1296-302. PubMed ID: 3239299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral contraceptive use and fibrocystic breast disease among pre- and postmenopausal women.
    Berkowitz GS; Kelsey JL; LiVolsi VA; Holford TR; Merino MJ; Ort S; O'Connor TZ; Goldenberg IS; White C
    Am J Epidemiol; 1984 Jul; 120(1):87-96. PubMed ID: 6741927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology.
    Pastides H; Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; Goldenberg IS
    J Natl Cancer Inst; 1983 Jul; 71(1):5-9. PubMed ID: 6575209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hormonal contraception--side effects and surgical aspects (author's transl)].
    Göretzlehner G; Carol W; Köhler G
    Zentralbl Chir; 1980; 105(24):1601-16. PubMed ID: 7015744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.